calendar
8,050 catalysts · 5,443 phase readout · 2,261 8k filing · 343 pdufa · 236 earnings · 2 approval · 1 adcom
8,050 catalysts · 5,443 phase readout · 2,261 8k filing · 343 pdufa · 236 earnings · 2 approval · 1 adcom
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 3.03, 5.03, 9.01
Items: 8.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 1.01, 8.01, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 1.01, 3.02, 9.01
Items: 1.01, 3.02, 8.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 8.01
Items: 5.02, 5.03, 8.01, 9.01
Items: 7.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 9.01
Items: 5.02
Items: 1.05
Items: 3.01
Items: 3.01
Items: 5.07
Items: 3.01
Items: 9.01
Items: 3.01
Items: 3.03, 5.03, 9.01
Items: 3.01
Items: 1.02, 9.01
Items: 1.01, 3.02, 5.03, 7.01, 8.01, 9.01
Items: 5.02
Items: 3.02, 7.01, 9.01
Items: 1.01, 2.03
Items: 3.01
Items: 1.01, 3.02, 9.01
Items: 3.02, 3.03, 5.03, 9.01
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Items: 5.07, 9.01
Items: 2.02, 9.01
Items: 1.01, 3.02, 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 1.01, 2.03, 3.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 1.01, 7.01, 9.01